SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Public ClinicalTrials.gov record NCT01470469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Tolerability of SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP).
Study identification
- NCT ID
- NCT01470469
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Shire
- Industry
- Enrollment
- 83 participants
Conditions and interventions
Interventions
- SPD503 (extended-release Guanfacine hydrochloride) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2012
- Primary completion
- Jul 14, 2013
- Completion
- Jul 14, 2013
- Last update posted
- Jun 9, 2021
2012 – 2013
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Research Group, Inc | Birmingham | Alabama | 35216 | — |
| Dr. Joseph H. Rodd | Carson | California | 90746 | — |
| Sun Valley Research | Imperial | California | 92251 | — |
| Irvine Center for Clinical Research | Irvine | California | 92618 | — |
| Sharp Mesa Vista Hospital, Clinical Research Department | San Diego | California | 92123 | — |
| Elite Clinical Trials, Inc | Wildomar | California | 92595 | — |
| Florida Clinical Research Center | Bradenton | Florida | 34201 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Kolin Research Group | Winter Park | Florida | 32789 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30308 | — |
| Institute of Behavioral Medicine, LLC | Smyrna | Georgia | 30080-6315 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| Rochester Center for Behavioral Medicine | Rochester Hills | Michigan | 48307 | — |
| Midwest Research Group | Saint Charles | Missouri | 63301 | — |
| Premier Psychiatric Group, LLC | Lincoln | Nebraska | 68526 | — |
| Center for Psychiatry and Behavioral Medicine, Inc | Las Vegas | Nevada | 89128 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| Columbia University, NY State Psychiatric Institute | New York | New York | 10032 | — |
| Weill Cornell Medical Center | New York | New York | 10065 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Richmond Behavioral Associates | Staten Island | New York | 10312 | — |
| Duke University Medical Center, Duke Child and Family Study Center | Durham | North Carolina | 27705-4596 | — |
| University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience | Cincinnati | Ohio | 45219 | — |
| University Hospitals of Cleveland Medical Center | Cleveland | Ohio | 44012 | — |
| Professional Psychiatric Services | Mason | Ohio | 45040 | — |
| North Star Research | Middleburg Heights | Ohio | 44130 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| Research Strategies of Memphis, LLC | Memphis | Tennessee | 38119 | — |
| FutureSearch Clinical Trials, LP | Austin | Texas | 78731 | — |
| Houston Clinical Trials LLC | Houston | Texas | 77098 | — |
| Ericksen Research and Development | Clinton | Utah | 84015 | — |
| NeuroScience, Inc. | Herndon | Virginia | 20170 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01470469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01470469 live on ClinicalTrials.gov.